Cuff-induced vascular intima thickening is influenced by titration of the Ace gene in mice

Physiological Genomics

Volumn 37, Issue 3, 2009, Pages 225-230

  Lacchini, Silvia ^a   Heimann, Andrea S ^a   Evangelista, Fabiana S ^a   Cardoso, Leandro ^a   Silva, Gustavo J J ^a   Krieger, José E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin I converting enzyme; Gene titration; Transgenic mice; Vascular injury

Indexed keywords

ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD PRESSURE CUFF; CONTROLLED STUDY; ENZYME ACTIVITY; FEMORAL ARTERY; GENE EXPRESSION; HEMODYNAMICS; INTIMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CONSTRICTION; ENALAPRIL; FEMORAL ARTERY; GENE DOSAGE; LOSARTAN; MICE; MICE, TRANSGENIC; PEPTIDYL-DIPEPTIDASE A; RENIN-ANGIOTENSIN SYSTEM; SPECTROMETRY, FLUORESCENCE; TUNICA INTIMA;

MUS; MUS MUSCULUS;

EID: 66349094046     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.90288.2008     Document Type: Article

References (34)

1. Agema WR, Jukema JW, Zwinderman AH, van der Wall EE. A meta-analysis of the angiotensin-converting enzyme gene polymorphism and restenosis after percutaneous transluminal coronary revascularization: evidence for publication bias. Am Heart J 144: 760-768, 2002. (Pubitemid 35335166)
2. Aitman TJ, Dong R, Vyse TJ, Norsworthy PJ, Johnson MD, Smith J, Mangion J, Roberton-Lowe C, Marshall AJ, Petretto E, Hodges MD, Bhangal G, Patel SG, Sheehan-Rooney K, Duda M, Cook PR, Evans DJ, Domin J, Flint J, Boyle JJ, Pusey CD, Cook HT. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 439: 851-855, 2006. (Pubitemid 43255703)
3. Akishita M, Shirakami G, Iwai M, Wu L, Aoki M, Zhang L, Toba K, Horiuchi M. Angiotensin converting enzyme inhibitor restrains inflammation-induced vascular injury in mice. J Hypertens 19: 1083-1088, 2001. (Pubitemid 32493642)
4. Alexiou T, Boon WM, Denton DA, Nicolantonio RD, Walker LL, McKinley MJ, Campbell DJ. Angiotensinogen and angiotensin-converting enzyme gene copy number and angiotensin and bradykinin peptide levels in mice. J Hypertens 23: 945-954, 2005. (Pubitemid 40637912)
5. Alves MF, Araujo MC, Juliano MA, Oliveira EM, Krieger JE, Casarini DE, Juliano L, Carmona AK. A continuous fluorescent assay for the determination of plasma and tissue angiotensin I-converting enzyme activity. Braz J Med Biol Res 38: 861-868, 2005. (Pubitemid 40932238)
6. Bonnici F, Keavney B, Collins R, Danesh J. Angiotensin converting enzyme insertion or deletion polymorphism and coronary restenosis: meta-analysis of 16 studies. BMJ 325: 517-520, 2002.
7. Booth RF, Martin JF, Honey AC, Hassall DG, Beesley JE, Moncada S. Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation. Atherosclerosis 76: 257-268, 1989. (Pubitemid 19101045)
8. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
9. Eto H, Biro S, Miyata M, Kaieda H, Obata H, Orihara K, Tei C. Angiotensin II type 1 receptor participates in extracellular matrix production in the late stage of remodeling after vascular injury. Cardiovasc Res 59: 200-211, 2003. (Pubitemid 36776386)
10. Evangelista FS, Krieger JE. The influence of ACE on exercise training-induced cardiac hypertrophy in mice: a gene dosage study. Physiol Genomics 27: 231-236, 2006. (Pubitemid 46708776)
11. Fukuhara M, Geary RL, Diz DI, Gallagher PE, Wilson JA, Glazier SS, Dean RH, Ferrario CM. Angiotensin-converting enzyme expression in human carotid artery atherosclerosis. Hypertension 35: 353-359, 2000. (Pubitemid 30054199)
12. Horiuchi M, Cui TX, Li Z, Li JM, Nakagami H, Iwai M. Fluvastatin enhances the inhibitory effects of a selective angiotensin II type 1 receptor blocker, valsartan, on vascular neointima formation. Circulation 107: 106-112, 2003. (Pubitemid 36070941)
13. Katzov H, Bennet AM, Kehoe P, Wiman B, Gatz M, Blennow K, Lenhard B, Pedersen NL, de Faire U, Prince JA. A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity. Hum Mol Genet 13: 2647-2657, 2004. (Pubitemid 39485413)
14. Kockx MM, De Meyer GR, Andries LJ, Bult H, Jacob WA, Herman AG. The endothelium during cuff-induced neointima formation in the rabbit carotid artery. Arterioscler Thromb 13: 1874-1884, 1993. (Pubitemid 23360576)
15. Krege JH, John SW, Langenbach LL, Hodgin JB, Hagaman JR, Bachman ES, Jennette JC, O'Brien DA, Smithies O. Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 375: 146-148, 1995.
16. Krege JH, Kim HS, Moyer JS, Jennette JC, Peng L, Hiller SK, Smithies O. Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis. Hypertension 29: 150-157, 1997. (Pubitemid 27074036)
17. Lafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y, Scherer SW, Lee C. Detection of large-scale variation in the human genome. Nat Genet 36: 949-951, 2004. (Pubitemid 39167488)
18. Lusis AJ. Atherosclerosis. Nature 407: 233-241, 2000.
19. Moroi M, Zhang L, Yasuda T, Virmani R, Gold HK, Fishman MC, Huang PL. Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J Clin Invest 101: 1225-1232, 1998. (Pubitemid 28145238)
20. Ohtani K, Egashira K, Ihara Y, Nakano K, Funakoshi K, Zhao G, Sata M, Sunagawa K. Angiotensin II type 1 receptor blockade attenuates in-stent restenosis by inhibiting inflammation and progenitor cells. Hypertension 48: 664-670, 2006. (Pubitemid 44843870)
21. 2 receptor expression. Hypertension 46: 577-583, 2005.
22. Pereira AC, Morandini Filho AA, Heimann AS, Rabak ET, Vieira AP, Mota GF, Krieger JE. Serum angiotensin converting enzyme activity association with the I/D polymorphism in an ethnically admixtured population. Clin Chim Acta 360: 201-204, 2005. (Pubitemid 41225414)
23. Ploplis VA, Cornelissen I, Sandoval-Cooper MJ, Weeks L, Noria FA, Castellino FJ. Remodeling of the vessel wall after copper-induced injury is highly attenuated in mice with a total deficiency of plasminogen activator inhibitor-1. Am J Pathol 158: 107-117, 2001. (Pubitemid 32096476)
24. Rakugi H, Kim DK, Krieger JE, Wang DS, Dzau VJ, Pratt RE. Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis. J Clin Invest 93: 339-346, 1994. (Pubitemid 24030854)
25. Ribichini F, Pugno F, Ferrero V, Bussolati G, Melissano G, Chiesa R, Di Mario C, Colombo A. Angiotensin-converting enzyme tissue activity in the diffuse in-stent restenotic plaque. Circulation 101: E33-E35, 2000.
26. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 340: 115-126, 1999. (Pubitemid 29054847)
27. Sales VL, Sukhova GK, Lopez-Ilasaca MA, Libby P, Dzau VJ, Pratt RE. Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution. Circulation 112: 3328-3336, 2005. (Pubitemid 43739379)
28. Sayed-Tabatabaei FA, Houwing-Duistermaat JJ, van Duijn CM, Witteman JC. Angiotensin-converting enzyme gene polymorphism and carotid artery wall thickness: a meta-analysis. Stroke 34: 1634-1639, 2003. (Pubitemid 36842616)
29. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, Lundin P, Maner S, Massa H, Walker M, Chi M, Navin N, Lucito R, Healy J, Hicks J, Ye K, Reiner A, Gilliam TC, Trask B, Patterson N, Zetterberg A, Wigler M. Large-scale copy number polymorphism in the human genome. Science 305: 525-528, 2004. (Pubitemid 38971344)
30. Silva GJ, Moreira ED, Pereira AC, Mill JG, Krieger EM, Krieger JE. ACE gene dosage modulates pressure-induced cardiac hypertrophy in mice and men. Physiol Genomics 27: 237-244, 2006. (Pubitemid 46708777)
31. Strawn WB, Ferrario CM, Tallant EA. Angiotensin-(1-7) reduces smooth muscle growth after vascular injury. Hypertension 33: 207-211, 1999. (Pubitemid 29065661)
32. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. Inflammation and angiotensin II. Int J Biochem Cell Biol 35: 881-900, 2003. (Pubitemid 36379329)
33. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86: 515-581, 2006.
34. Wilson DP, Saward L, Zahradka P, Cheung PK. Angiotensin II receptor antagonists prevent neointima proliferation in a porcine coronary artery organ culture model. Cardiovasc Res 42: 761-772, 1999. (Pubitemid 29298146)